Slow wave sleep disruption increases cerebrospinal fluid amyloid-β levels

Brain

Volumn 140, Issue 8, 2017, Pages 2104-2111

  Ju, Yo El S ^a   Ooms, Sharon J ^b,c   Sutphen, Courtney ^a   Macauley, Shannon L ^a   Zangrilli, Margaret A ^a   Jerome, Gina ^a   Fagan, Anne M ^a   Mignot, Emmanuel ^d   Zempel, John M ^a   Claassen, Jurgen A H R ^b,c   Holtzman, David M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c RADBOUD UNIVERSITY   (Netherlands)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

beta amyloid; EEG; sleep; slow wave activity; tau

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; APOLIPOPROTEIN E; CHI3L1 PROTEIN, HUMAN; CHITINASE 3 LIKE PROTEIN 1; OREXIN; PEPTIDE FRAGMENT; PROTEIN CEREBROSPINAL FLUID LEVEL; TAU PROTEIN;

ACTIMETRY; ADULT; AGED; CEREBROSPINAL FLUID; FEMALE; GENETICS; HUMAN; MALE; MIDDLE AGED; PHYSIOLOGY; POLYSOMNOGRAPHY; PROTEIN CEREBROSPINAL FLUID LEVEL; SLEEP; SLEEP DEPRIVATION;

ACTIGRAPHY; ADULT; AGED; AMYLOID BETA-PEPTIDES; APOLIPOPROTEINS E; CEREBROSPINAL FLUID PROTEINS; CHITINASE-3-LIKE PROTEIN 1; FEMALE; HUMANS; MALE; MIDDLE AGED; OREXINS; PEPTIDE FRAGMENTS; POLYSOMNOGRAPHY; SLEEP; SLEEP DEPRIVATION; TAU PROTEINS;

EID: 85028326037     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awx148     Document Type: Article

References (33)

1. Bateman RJ, Munsell LY, Morris JC, Swarm R, Yarasheski KE, Holtzman DM. Human amyloid-beta synthesis and clearance rates as measured in cerebrospinal fluid in vivo. Nat Med 2006; 12: 856-61.
2. Bero AW, Yan P, Roh JH, Cirrito JR, Stewart FR, Raichle ME, et al. Neuronal activity regulates the regional vulnerability to amyloid-b deposition. Nat Neurosci 2011; 14: 750-6.
3. Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989; 28: 193-213.
4. Cirrito JR, Yamada KA, Finn MB, Sloviter RS, Bales KR, May PC, et al. Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo. Neuron 2005; 48:913-22.
5. Fagan AM, Mintun MA, Mach RH, Lee S-Y, Dence CS, Shah AR, et al. Inverse relation between in vivo amyloid imaging load and CSF Ab42 in humans. Ann Neurol 2006; 59: 512-9.
6. Fagan AM, Mintun MA, Shah AR, Aldea P, Roe CM, Mach RH, et al. Cerebrospinal fluid tau and ptau181 increase with cortical amyloid deposition in cognitively normal individuals: Implications for future clinical trials of Alzheimer's disease. EMBO Mol Med 2009; 1: 371-80.
7. Folstein MF, Folstein SE, McHugh PR. Mini mental state examination. Lutz, FL: Psychological Assessment Resources; 2004.
8. Hoddes E, Zarcone V, Smythe H, Phillips R, Dement WC. Quantification of sleepiness: a new approach. Psychophysiology 1973; 10: 431-6.
9. Huang Y, Potter R, Sigurdson W, Santacruz A, Shih S, Ju YS, et al. Effects of age and amyloid deposition on Ab dynamics in the human central nervous system. Arch Neurol 2012; 69: 51-8.
10. Iber C. The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications. Darien IL: American Academy of Sleep Medicine; 2007.
11. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991; 14: 540-5.
12. Ju YS, McLeland JS, Toedebusch CD, Xiong C, Fagan AM, Duntley SP, et al. Sleep quality and preclinical Alzheimer disease. JAMA Neurol 2013; 70: 587-93.
13. Ju YS, Lucey BP, Holtzman DM. Sleep and Alzheimer disease pathology-a bidirectional relationship. Nat Rev Neurol 2014; 10: 115-9.
14. Ju YS, Finn MB, Sutphen CL, Herries EM, Jerome GM, Ladenson JH, et al. Obstructive sleep apnea decreases central nervous system-derived proteins in the cerebrospinal fluid. Ann Neurol 2016; 80: 154-9.
15. Kang JE, Lim MM, Bateman RJ, Lee JJ, Smyth LP, Cirrito JR, et al. Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle. Science 2009; 326: 1005-7.
16. Kushida CA, Chang A, Gadkary C, Guilleminault C, Carrillo O, Dement WC. Comparison of actigraphic, polysomnographic, and subjective assessment of sleep parameters in sleep-disordered patients. Sleep Med 2001; 2: 389-96.
17. Mignot E, Lammers GJ, Ripley B, Okun M, Nevsimalova S, Overeem S, et al. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol 2002; 59: 1553-62.
18. Nir Y, Staba RJ, Andrillon T, Vyazovskiy VV, Cirelli C, Fried I, et al. Regional slow waves and spindles in human sleep. Neuron 2011; 70: 153-69.
19. Ooms S, Overeem S, Besse K, Rikkert MO, Verbeek M, Claassen JA. Effect of 1 night of total sleep deprivation on cerebrospinal fluid bamyloid 42 in healthy middle-aged men: a randomized clinical trial. JAMA Neurol 2014; 71: 971-7.
20. Ooms SJ, Zempel JM, Holtzman DM, Ju YS. February 24, 2017. Automated selective disruption of slow wave sleep. J Neurosci Methods 281; 33-9.
21. Osorio RS, Ayappa I, Mantua J, Gumb T, Varga A, Mooney AM, et al. The interaction between sleep-disordered breathing and apolipoprotein E genotype on cerebrospinal fluid biomarkers for Alzheimer's disease in cognitively normal elderly individuals. Neurobiol Aging 2014; 35: 1318-24.
22. Pedrazzoli M, D'Almeida V, Martins PJ, Machado RB, Ling L, Nishino S, et al. Increased hypocretin-1 levels in cerebrospinal fluid after REM sleep deprivation. Brain Res 2004; 995: 1-6.
23. Potter R, Patterson BW, Elbert DL, Ovod V, Kasten T, Sigurdson W, et al. Increased in vivo amyloid-b42 production, exchange, and loss in presenilin mutation carriers. Sci Transl Med 2013; 5: 189ra77.
24. Qiu H, Zhong R, Liu H, Zhang F, Li S, LeW. Chronic sleep deprivation exacerbates learning-memory disability and Alzheimer's disease-like pathologies in AbPP(swe)/PS1(-E9) mice. J Alzheimers Dis 2016; 50: 669-85.
25. Roh JH, Huang Y, Bero AW, Kasten T, Stewart FR, Bateman RJ, et al. Disruption of the sleep-wake cycle and diurnal fluctuation of beta-amyloid in mice with Alzheimer's disease pathology. Sci Transl Med 2012; 4: 150ra122.
26. Roh JH, Jiang H, Finn MB, Stewart FR, Mahan TE, Cirrito JR, et al. Potential role of orexin and sleep modulation in the pathogenesis of Alzheimer's disease. J Exp Med 2014; 211: 2487-96.
27. Rothman SM, Herdener N, Frankola KA, Mughal MR, Mattson MP. Chronic mild sleep restriction accentuates contextual memory impairments, and accumulations of cortical Ab and pTau in a mouse model of Alzheimer's disease. Brain Res 2013; 1529: 200-8.
28. Schindler SE, Sutphen CL, Morris JC, Fagan AM. Upward drift in CSF Ab42 values over 10 years. Alzheimers Dement 2016; 12(7, Supplement): P183.
29. Spira AP, Gamaldo AA, An Y, Wu MN, Simonsick EM, Bilgel M, et al. Self-reported sleep and b-amyloid deposition in community-dwelling older adults. JAMA Neurol 2013; 70: 1537-43.
30. Sutphen CL, Jasielec MS, Shah AR, Macy EM, Xiong C, Vlassenko AG, et al. Longitudinal cerebrospinal fluid biomarker changes in preclinical Alzheimer disease during middle age. JAMA Neurol 2015; 72: 1029-42.
31. Varga AW, Wohlleber ME, Giménez S, Romero S, Alonso JF, Ducca EL, et al. Reduced slow-wave sleep is associated with high cerebrospinal fluid Ab42 levels in cognitively normal elderly. Sleep 2016; 39: 2041-8.
32. Xie L, Kang H, Xu Q, Chen MJ, Liao Y, Thiyagarajan M, et al. Sleep drives metabolite clearance from the adult brain. Science 2013; 342: 373-7.
33. Yamada K, Holth JK, Liao F, Stewart FR, Mahan TE, Jiang H, et al. Neuronal activity regulates extracellular tau in vivo. J Exp Med 2014; 211: 387-93.